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We investigated the incidence of bloodstream infections (BSIs) in trauma
emergency department (ED) and intensive care unit (ICU), to assess ED- and ICU-
related predictors of BSI and to describe the most common bacteria causing BSI and
their antimicrobial resistance markers. A prospective study was conducted in two
trauma ICUs of the ED of Clinical Center of Serbia. Overall, 62 BSIs were diagnosed
in 406 patients, of which 13 were catheter-related BSI (3.0/1,000 CVC-days) and 30
BSIs of unknown origin, while 15% were attributed to ED CVC exposure. Lactate
≥2 mmol/L and SOFA score were independent ED-related predictors of BSI, while
CVC in place for >7 days and mechanical ventilation >7 days were significant ICU-
related predictors. The most common bacteria recovered were Acinetobacter spp.,
Klebsiella spp., and Pseudomonas aeruginosa. All Staphylococcus aureus and
coagulase-negative staphylococci isolates were methicillin-resistant, whereas 66% of
Enterococcus spp. were vancomycin-resistant. All isolates of Enterobacteriaceae
were resistant to third-generation cephalosporins, whereas 87.5% of P. aeruginosa and
95.8% of Acinetobacter spp. isolates were resistant to carbapenems. ED BSI con-
tributes substantially to overall ICU incidence of BSI. Lactate level and SOFA score
can help to identify patients with higher risk of developing BSI. Better overall and
CVC-specific control measures in patients with trauma are needed.
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Introduction
Healthcare-associated bloodstream infections (HA-BSIs) are considered as
major preventable threat to healthcare and patient safety. They approximately
affect 4% of all critically ill patients and are the second most common healthcare-
associated infection (HAI) among patients staying more than 48 h in intensive care
unit (ICU) [1]. Moreover, HA-BSI is independently associated with increased risk
of both short- and long-term mortality in critically ill patients [2, 3].
Patients with trauma represent considerable part of patients admitted in
emergency department (ED) since the advances in initial resuscitation of
critically injured patients increased survival after the injury. However, those
who survive initial trauma are at particular risk of developing BSI over the
course of ED and ICU treatment, which is enabled by exposure to numerous
invasive devices and facilitated by disrupted barriers and altered immune
response [4]. Consequently, BSI is two times more frequent in patients with
trauma compared to surgical patients and after ventilator-associated pneumonia,
it is the second most frequent HAI in patients with trauma [5, 6]. Yet,
surveillance studies and preventative measures usually target BSI in ICU
inpatients and little is known about contribution of ED in occurrence of BSI.
In Serbia, trauma represents the third cause of mortality and every tenth person
dies from injury [7]. Despite this, there is neither in depth data on incidence of
BSI in patients with trauma in both ED or ICU department in Serbia nor the
countries of the Southeastern–European Region.
In critically ill patients, healthcare-acquired BSI is usually accompanied
with sepsis, which has significant impact on patient’s clinical course, since
primary bacteremia is associated with higher mortality compared with pulmonary
and abdominal sources of sepsis [8]. Clinicians mostly rely on positive blood
culture in early diagnosis of BSI and sepsis as it helps distinguishing infectious
from non-infectious inflammatory response and allows optimization of empirical
antimicrobial therapy. However, even when requested on time, blood culture
requires up to 48 h to yield results, while every hour of the delay of the antibiotics
initiation in patients with sepsis increases risk for unfavorable outcome [9]. Hence,
search for factors available in first hours of admission to ED could help to select
patient at risk for development of BSI and sepsis later over the course of ED and
ICU treatment. Moreover, choosing the adequate empirical antimicrobial therapy
requires knowledge about predominant causative agents and their resistance
patterns in particular group of patients and medical setting. This is allowed by
constant update of emergency care providers on main antimicrobial markers of
pathogens causing BSI, as it has been shown that feedback of surveillance data to
clinical staff is significant tool in reducing the rates of HAI [10].
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Therefore, the aims of this study were: (a) to estimate incidence of bacterial
BSI in ICU patients with trauma and fraction of BSI cases attributed to ED; (b) to
identify which factors among those assessed in the first hours in ED and those
estimated later on in ICU are independent predictors of BSI in patients with
trauma; and (c) to estimate most common bacteria causing BSI and their most
common resistance markers in patients with trauma in Emergency Center in
Serbia. To assess this, we used patients with trauma as a pilot population since they
are at highest risk of acquiring HAI, and moreover, those who sustained trauma are
considered not to have infection on the admission.
Materials and Methods
Study setting and infection control measures
Emergency Department of Clinical Center of Serbia is a 308-bed tertiary
teaching hospital and the sole referral and adult care trauma center serving the
southern and central areas of Serbia. Two trauma-surgical ICUs together comprise 25
beds and have approximately 800 admissions annually. Nurse-to-patient ratio is 1:3.
Hand hygiene policy includes alcohol-based hand sanitizers placed at each bedside in
each ICU room, according to the national recommendations, which are adopted from
World Health Organization’s hand hygiene guidelines [11]. Central venous catheter
(CVC) insertion and maintenance are done following the guidelines of American
Society of Anesthesiologists for insertion and maintenance of CVC [12]. Placement
of the CVC is done in aseptic conditions either by the anesthesiology specialist or by
anesthesiology resident under the supervision of a specialist. Hand hygiene (using
alcohol-based hand rubs), universal barrier precautions (use of a cap, mask, sterile
gown, sterile gloves, and a sterile partial-body drape), and skin preparation (using
chlorhexidine) are performed prior and during every CVC insertion.
The infection control team in the ED was established in 2001 within the
Department for HAI at the Clinical Center of Serbia. It comprises one infection
control epidemiologist and one infection control nurse who deliver general and
specific infection control measures recommended by the National Infection
Control Committee. No modifications in infection control measures were observed
during the study period.
Study design and patients
A prospective surveillance study was conducted at the Emergency Depart-
ment of Clinical Center of Serbia in a year and a half period (from November 2014
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to April 2016). All consecutive adult patients with trauma were admitted to one of
two trauma ICUs from ED and those who spent more than 48h in ICU were
eligible for the study. Patients were transferred either from the ED directly to the
ICU or via operating room if urgent surgery was indicated. Exclusion criteria were
unspecified injuries, non-traumatic injures (poisoning, drowning, and suffocation),
hip fractures, late effect of injury, superficial injuries, and foreign bodies. Patients
with isolated brain injuries caused by low falls due to non-traumatic intracranial
hemorrhage were also excluded.
The study was approved by the Ethics Committee of the Clinical Center of
Serbia (no. 1358/19) and by the Ethics Committee of the Faculty of Medicine at
the University of Belgrade, Serbia (no. 29/X-5).
Surveillance and case definitions
Patients were prospectively assessed for the presence of BSI by daily visits
by attending physicians and infection control epidemiologists and examination of
records of patients, clinical course, and microbiological results. The centers for
disease and prevention definitions were used to diagnose BSI [13]. BSI was
diagnosed when clinical symptoms of infection were present 48 h from admission,
and laboratory-confirmed causative agent was isolated, i.e., recognized pathogen
cultured from one or more blood cultures or common skin contaminant cultured
from two or more blood cultures.
BSIs were reported as primary and secondary BSI. Primary BSI was defined
as BSI not related to another infection site and for the purpose of the comparability
of results with studies, which have used European Centre for Disease Prevention
and Control criteria, these were divided into catheter-related BSI (CR-BSI) and
BSI of unknown origin [14, 15]. All other cases of BSI, i.e., those related to
another infection site (same organism cultured from bloodstream and primary HAI
site, and the organisms exhibit same antibiogram) were considered as secondary
BSI [16]. A microbiological proof of a catheter-related infection was warranted
when the same organism was isolated from a peripheral blood culture and a
catheter blood or as a positive semi-quantitative CVC culture (>15 CFU per
catheter segment).
The extent of exposure to CVC was described as device utilization ratio,
calculated by dividing the total number of CVC-days by total number of patient-
days. The presence of multiple CVCs in a single patient on a single day was
represented as one CVC-day. Cumulative incidence (number of BSI episodes
per 100 patients) and incidence rate (number of BSI per 1,000 patient-days or
1,000 CVC-days) were calculated as outcome measures.
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Definitions
Severity of trauma was assessed through the Abbreviated Injury Scale (AIS)
and Injury Severity Score (ISS). Glasgow Coma Scale (GCS) was used to measure
conscious level before sedation. Severe trauma brain injury (TBI) was defined as
AIShead ≥ 3 and GCS ≤ 8. The Acute Physiology and Chronic Health Evaluation
II score (APACHE II) and Sequential Organ Failure Assessment (SOFA) score are
a severity-of-disease classification scores and were calculated within 24 h of
admission of a patient in ED. Comorbidity polypharmacy score was defined as the
sum of total number of pre-admission medications and the total number of
comorbidities for each patient [17].
Microbiological assessment
Isolation and identification of bacterial strains were carried out following
standard microbiological procedures. Antimicrobial susceptibility was performed
using the Kirby–Bauer disk diffusion method and a Vitek2 automated system
(bioMérieux, Marcy-I’Etoile, France). Zone diameter was measured and inter-
preted according to the Clinical and Laboratory Standards Institute guidelines
[18]. Strains that showed intermediate susceptibility and resistance to the specific
antibiotic were considered resistant. Antimicrobial resistance (AMR) was pre-
sented through the AMR markers as follows: for Staphylococcus aureus: markers
of methicillin (oxacillin, cefoxitin, or methicillin) resistance –methicillin-resistant
Staphylococcus aureus; for Enterococcus spp.: markers of glycopeptide resistance –
vancomycin-resistant enterococci; for Enterobacteriaceae: third-generation cepha-
losporins (ceftriaxone, cefotaxime, or ceftazidime) and carbapenems (imipenem,
meropenem or doripenem, and ertapenem) resistance; and for Gram-negative rods
(Pseudomonas aeruginosa and Acinetobacter spp.): antipseudomonal carbapenems
(imipenem or meropenem) and colistin resistance.
Statistical analysis
For continuous variables, the Kolmogorov–Smirnov test was used to assess
the assumption of normality. Continuous data are presented as the mean±
standard deviation or median (interquartile range) and categorical data are
presented as numbers (percentages). Univariate analysis of significant difference
between groups of patients with and without BSI for continuous data was
performed using Student’s t test for normally distributed data or Mann–Whitney
U test for skewed data, and for categorical data using the Pearson’s χ2 test
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(less than 20% of cells with expected frequencies <5 and no cell has expected
frequency <1) or Fisher’s exact test (for 2 × 2 contingency tables where more than
20% of cells have expected frequencies<5). A multivariate logistic regression was
applied to indentify independent predictors of BSI. Variables were entered into the
multivariate logistic regression model based on statistical significance (p< 0.25 in
univariate analysis) and clinical significance, and stepwise logistic regression was
performed. Odds ratios (ORs) with 95% confidence intervals (95% CIs) were
computed. Hosmer–Lemeshow goodness-of-fit test and area under the receiver-
operating characteristic curve (AUC) were applied to assess overall model fit. C
statistics was calculated for two distinct models (with and without predictors from
ED) as a measure of discrimination of BSI and non-BSI cases and comparison of
AUCs was done using DeLong’s method [19]. All statistical tests were two-sided
and were performed at a 5% significance level. Statistical analyses were performed
using SPSS version 20.0 software (IBM-SPSS Inc., Armonk, NY, USA).
Results
Study population
During the study period, 848 patients with trauma were admitted to ED and
consequently to one of two trauma-surgical ICUs, of which 547 were adult
patients who were hospitalized for more than 48 h. Thirty-one patients were
excluded due to non-traumatic mechanisms of injury (poisoning, drowning, and
suffocation) and 36 were excluded due to late effect of injuries, superficial injuries,
or foreign bodies. In addition, 74 patients were excluded due to diagnosis of burns,
hip fractures, or isolated brain injuries caused by non-traumatic injury, such as
spontaneous intracranial bleeding. This led to the sample of 406 patients with
trauma included in the final analysis. The process of patient selection is depicted in
Figure 1.
A cohort of 406 patients with trauma (312 males and 94 females) were followed
for 5,258 patient-ICU days. Median length of stay was 9 days (range: 2–131).
Incidence of BSI in ED and ICU
Out of 406 patients with trauma, 57 patients had at least one episode of BSI
(cumulative incidence 14.0%). Overall, 62 BSI episodes were diagnosed in 57
patients with the incidence rate of 11.8/1,000 patient/days. Out of 62 BSI episodes,
19 (30.6%) BSI episodes infection cite was identified and those were considered as
secondary BSI. For 30 BSI episodes (48.4%), no source of infection could be
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identified while 13 BSI (21.0%) were ascertained as CR-BSI, which over the 4,295
catheter-days resulted in incidence rate of 3.0/1,000 CVC-days. Out of 13
CR-BSI, 2 were attributed to ED since the CVC was placed in ED, which resulted
in IR= 3.7/1,000 CVC/days (532 CVC-days in ED).
Clinical characteristics of patients at admission to ED
Table I provides comparison of demographic characteristics, underlying
conditions, and data about severity of the disease at the admission to ED, between
patient with and without BSI. There was no significant difference in demographics
and comorbidities in patients with BSI and those without BSI. However, signifi-
cantly more patients with BSI had received cardiopulmonary resuscitation on
scene or at admission (p= 0.026), had lower median GCS on admission
(p= 0.001), had almost twice more patients with lactate level ≥2 mmol/L
(p< 0.001) and in higher percent required mechanical ventilation (p< 0.001) as
well as massive transfusion (p= 0.011) and emergency surgery (p= 0.034) on
admission. Patients with BSI evinced more severe medical condition on admission
848 patients with trauma admitted to 
ED
831 patients
284 Excluded for < 48h in ICU
547 patients
Excluded for diagnosis of: hip 
fractures (23), burns (8), late effect 
of injury (5), superficial injury (24) 
or foreign bodies (7)
406 patients included in analysis
Excluded for non-trauma diagnosis: 
poisoning (11), drowning (8), 
suffocation (12)
516 patients
17 Excluded for < 18 years old
449 patients
43 Excluded for isolated brain injury 
caused by intracranial hemorrhagia 
of non-traumatic cause
Figure 1. Flowchart of patient selection
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Table I. Characteristics of patients with trauma with and without BSI
Characteristic
All patients
(n= 406)
BSI
(n= 57)
Non-BSI
(n= 349) p value
General characteristics
Age 49 (35) 52 (37) 48 (34) 0.525
Male gender 312 (76.8) 44 (77.2) 268 (76.8) 0.947
Comorbidities 165 (40.6) 23 (40.4) 142 (40.7) 1.000
Cardiac disease 94 (23.2) 17 (29.8) 77 (22.1) 0.235
Chronic pulmonary disease 12 (3.0) 2 (3.5) 10 (2.9) 0.679
Chronic liver disease 3 (0.7) 0 (0.0) 3 (0.9) 1.000
Chronic renal disease 4 (1.0) 1 (1.8) 3 (0.9) 0.455
Diabetes mellitus 16 (3.9) 3 (5.3) 13 (3.7) 0.480
Immunocompromised 6 (1.7) 0 (0.0) 6 (1.7) 1.000
Carcinoma 10 (2.5) 0 (0.0) 10 (2.9) 0.369
Number of comorbidities
0 241 (59.4) 34 (59.6) 207 (59.3) 0.883
1 111 (27.3) 17 (29.8) 94 (26.9)
2 32 (7.9) 4 (7.0) 28 (8.0)
≥3 22 (5.4) 2 (3.5) 20 (5.7)
Comorbidity polypharmacy score 1.6± 2.5 1.8± 2.6 1.6± 3.0 0.519
Clinical characteristics at admission to ED
Type of admission
ED directly 290 (71.4) 34 (59.6) 256 (73.4) 0.034
OR 116 (28.6) 23 (40.4) 93 (26.6)
Glasgow coma score 14 (6) 12 (6) 14 (5) 0.001
≤8 87 (21.5) 15 (26.3) 72 (20.7) 0.033
9–12 61 (15.1) 914 (24.6) 47 (13.5)
≥13 257 (63.5) 28 (49.1) 229 (65.8)
Lactate (mmol/L) 1.5 (1.8) 2.3 (3.1) 1.4 (1.7) <0.001
Lactate ≥2 mmol/L 160 (39.4) 36 (63.2) 124 (35.5) <0.001
Mechanical ventilation 236 (58.1) 45 (78.9) 191 (54.7) <0.001
Intubation place
At scene 12 (5.1) 0 (0.0) 12 (6.3) 0.095
ED/OR 160 (67.8) 37 (82.2) 123 (64.4)
ICU 14 (5.9) 2 (4.4) 12 (6.3)
Other hospital 50 (21.2) 6 (13.3) 44 (23.0)
State on admission
Coma 76 (18.7) 14 (24.6) 62 (17.8) 0.223
Hypotension 67 (16.5) 17 (29.8) 50 (14.3) 0.003
Hemorrhagic shock 24 (5.9) 9 (15.8) 15 (4.3) 0.003
Massive transfusion 15 (3.7) 6 (10.5) 9 (2.6) 0.011
CPR 9 (2.2) 4 (7.0) 5 (1.4) 0.026
Emergency surgery 116 (28.6) 23 (40.4) 93 (26.6) 0.034
Abdominal surgery 56 (13.8) 14 (24.6) 42 (12.0) 0.011
Splenectomy 27 (6.7) 7 (12.3) 20 (5.7) 0.066
Neurosurgery 28 (6.9) 1 (1.8) 27 (7.7) 0.154
Thoracic surgery 3 (0.7) 0 (0.0) 3 (0.9) 1.000
Pelvic surgery 6 (1.5) 2 (3.5) 4 (1.1) 0.200
Maxillofacial surgery 1 (0.2) 1 (1.8) 0 (0.0) 0.140
Orthopedic surgery 23 (5.7) 4 (7.0) 19 (5.4) 0.547
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considering higher median APACHE II and SOFA score in BSI group (p< 0.001
for both). Regarding the exposure to invasive devices over the course of ED and
ICU treatment, median number of days spent with CVC in place or on mechanical
ventilation was significantly higher in patients who acquired BSI compared to
those who did not (p< 0.001 for both).
Table II shows distribution and comparison of injury patterns and severity in
patients with trauma with and without BSI. Blunt trauma was a more common type
of injury in both groups of patients. Polytrauma (p< 0.001) and abdominal injury
(p< 0.001) were more frequent injury pattern in patients with BSI. They also had
significantly more severe injuries on face (p= 0.017), abdomen (p< 0.001), and
external body surface (p= 0.037) according to AIS score ≥3 for these body
regions. Overall, patients with BSI had more severe injuries according to higher
ISS (24.1± 8.3 vs. 19.3± 8.4, p< 0.001) and significantly higher percent of BSI
patient had critically severe injuries (45.6% vs. 24.6%, p= 0.002).
Predictors of BSI
Multivariate logistic regression of factors associated with BSI was applied
and model was started with 34 variables that were statistically or clinically
associated with BSI in univariate analysis. Variables that remained independently
associated with occurrence of BSI in multivariate logistic regression model were
lactate concentration ≥2 mmol/L (OR= 2.05; 95% CI= 1.07–43.89), SOFA score
(OR= 1.21; 95% CI= 1.07–1.36), CVC in place for more than 7 days (OR= 4.94;
95% CI= 1.97–12.26), and mechanical ventilation more than 7 days (OR= 2.69;
Table I. Characteristics of patients with trauma with and without BSI (Continued)
Characteristic
All patients
(n= 406)
BSI
(n= 57)
Non-BSI
(n= 349) p value
Other surgery 13 (3.2) 3 (5.3) 10 (2.9) 0.340
APACHE II score 9 (10) 12 (9) 8 (9) <0.001
SOFA score 4 (3) 6 (4) 3 (3) <0.001
Device exposure
CVC-days – median 7 (9) 16 (24) 6 (8) <0.001
CVC-days>2 days 326 (80.3) 65 (100) 261 (76.5) <0.001
MV-days – median 3 (7) 13 (14) 2 (5) <0.001
CVC-days>7 days 197 (48.5) 50 (87.7) 147 (42.1) <0.001
Note:Values are number (%), mean± SD or median (IQR). p value corresponds to comparison between BSI
and non-BSI. BSI: bloodstream infection; ED: emergency department; OR: operating room; CPR:
cardiopulmonary resuscitation; APACHE II score: Acute Physiology and Chronic Health Evaluation II
Score; SOFA score: Sequential Organ Failure Assessment score; CVC: central venous catheter; MV:
mechanical ventilation.
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Table II. Characteristics of injuries in patients with trauma with and without BSI
Characteristic
All patients
(n= 406) BSI (n= 65)
Non-BSI
(n= 341) p value
Type of injury 0.322
Blunt 387 (95.3) 53 (93.0) 334 (95.7)
Penetrating 19 (4.7) 4 (7.0) 15 (4.3)
Mechanism of injury 0.013
Road traffic accidents 228 (56.2) 41 (71.9) 187 (53.6)
Fall from the height 74 (18.2) 6 (10.5) 68 (19.5)
Low fall 39 (9.6) 1 (1.8) 38 (10.9)
Home and leisure injury 21 (5.2) 2 (3.5) 19 (5.4)
Gun shoot injury 13 (3.2) 4 (7.0) 9 (2.6)
Physical assault 14 (3.4) 3 (5.3) 11 (3.2)
Other 17 (4.2) 0 (0.0) 17 (4.9)
Injury pattern 0.231
Isolated TBI 29 (7.1) 1 (1.8) 28 (8.0)
TBI+ other injuries 205 (50.5) 31 (54.4) 174 (49.9)
Polytrauma without TBI 172 (42.4) 25 (43.9) 147 (42.1)
No. of injured body regions <0.001
1 43 (10.6) 1 (1.8) 42 (12.0)
2 101 (24.9) 6 (10.5) 95 (27.2)
≥3 262 (64.5) 50 (87.7) 212 (60.7)
Distribution of injuries
Head and neck 234 (57.6) 32 (56.1) 202 (57.9) 0.805
Face 128 (32.5) 19 (33.3) 109 (31.2) 0.752
Thorax 270 (66.5) 41 (71.9) 229 (65.6) 0.349
Abdomen 103 (25.4) 27 (47.4) 76 (21.8) <0.001
Extremities/pelvis 212 (52.2) 36 (63.2) 176 (50.4) 0.074
Spine 137 (33.7) 20 (35.1) 117 (33.5) 0.817
External 133 (32.8) 25 (43.9) 18 (30.9) 0.054
Injury severity
AIShead and neck ≥ 3 179 (44.1) 23 (40.4) 156 (44.7) 0.540
AISface ≥ 3 41 (10.3) 11 (19.3) 31 (8.9) 0.017
AISthorax ≥ 3 120 (29.6) 21 (36.8) 99 (28.4) 0.194
AISabdomen ≥ 3 77 (19.0) 23 (40.4) 54 (15.5) <0.001
AISextremities/pelvis ≥ 3 77 (19.0) 11 (19.3) 66 (18.9) 0.945
AISspine ≥ 3 85 (20.9) 11 (19.3) 74 (21.2) 0.743
AISexternal ≥ 3 4 (1.0) 2 (3.5) 2 (0.6) 0.037
ISS 19.9± 8.5 24.1± 8.3 19.3± 8.4 <0.001
Mild (<9) 25 (6.2) 0 (0.0) 25 (7.2) 0.002
Moderate (9–15) 94 (23.2) 7 (12.3) 87 (24.9)
Severe (16–24) 175 (43.1) 24 (42.1) 151 (43.3)
Critical (25–75) 112 (27.6) 26 (45.6) 86 (24.6)
Note: p value corresponds to comparison between BSI and non-BSI. BSI: bloodstream infection; TBI:
trauma brain injury; AIS: Abbreviated Injury Scale; ISS: Injury Severity Score.
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95% CI= 1.35–5.38; Table III). The model fit the data properly since the Hosmer–
Lemeshow test was insignificant (p= 0.620). The discrimination of the model was
good according to AUC= 0.838 (95% CI= 0.800–0.874). However, after con-
trolling for patients’ characteristics (age, gender, and comorbidities), injury
severity (severe TBI and ISS) and presence of hemorrhagic shock on admission,
lactate concentration ≥2 mmol/L did not remain statistically significant predictor
(OR= 1.93; 95% CI= 0.984–3.795).
In order to estimate the impact of ED predictors in the model, we compared
AUCs of models with only ICU variables [CVC in place for more than 7 days and
mechanical ventilation (MV) more than 7 days] with full model with ED variables
added (lactate ≥2 mmol/L and SOFA score). Inclusion of variables from ED
significantly improved discriminative accuracy of the model since AUC increased
from fair (AUC= 0.785; 95% CI= 0.741–0.824) to good accuracy (AUC=
0.839; 95% CI= 0.800–0.874), respectively (p= 0.0004; Figure 2).
Causative agents and AMR
Sixty-nine pathogens were obtained from 62 BSI episodes, of which 6 were
polymicrobial (5 isolates with 2 bacteria and 1 with 3 bacteria). The most common
pathogens recovered were Gram-negative bacteria (Acinetobacter spp., Klebsiella
pneumoniae, Pseudomonas spp., and Klebsiella spp.) accounting for 71% of all
isolates (Table IV). AMR markers in bacteria causing BSI in patients with trauma
are presented in Table V. While all isolates of S. aureus and coagulase-negative
staphylococci (CoNS) were methicillin-resistant, 66% of Enterococcus spp. were
resistant to vancomycin. Regarding Enterobacteriaceae, all isolates of Klebsiella
spp., K. pneumoniae, Proteus spp., Serratia spp., and Providentia spp. were
Table III. Multivariate logistic regression of predictors of BSI in patients with trauma
Variable OR [95% CI] p value Adjusted p value*
Lactate ≥2mmol/L 2.05 [1.07–3.89] 0.029 0.056
SOFA score at admission 1.21 [1.07–1.36] 0.002 0.004
ICU CVC-days>7 4.94 [1.97–12.26] 0.001 0.002
MV-days>7 2.69 [1.35–5.38] 0.005 0.010
HL-GOF χ2= 6,248; df= 8 0.620 0.643
AUC [95% CI] 0.838 [0.800–0.874]
Note: SOFA score: sequential organ failure assessment score; OR: odds ratio; ICU: intensive care unit;
CVC: central venous catheter; HL-GOF: Hosmer and Lemeshow goodness of fit; MV: mechanical
ventilation; BSI: bloodstream infection; AUC: area under the receiver-operator characteristic curve;
CI: confidence interval.
*Adjusted for age, gender, comorbidities, severe trauma brain injury (AIShead ≥ 3 and GCS ≤ 8), trauma
severity (ISS), and hemorrhagic shock.
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Figure 2. Comparison of AUCs of models with and without ED predictors. AUC difference= 0.055;
[95% CI= 0.0.3–0.08]; p= 0.0004
Table IV. Distribution of bacteria causing BSI by type of source
Pathogen
Primary BSI (n= 43)
Secondary BSI
(n= 19) Total
CR-BSI
(n= 13)
Unknown source
(n= 30)
S. aureus 2 (15.4) 2 (6.1) 2 (8.7) 6 (8.7)
Enterococcus spp. 0 (0.0) 5 (15.1) 1 (4.3) 6 (8.7)
Klebsiella spp. 1 (7.7) 8 (24.2) 8 (34.7) 17 (24.6)
E. coli 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Proteus spp. 0 (0.0) 1 (3.0) 0 (0.0) 1 (1.5)
Serratia spp. 0 (0.0) 1 (3.0) 0 (0.0) 1 (1.5)
Providencia spp. 0 (0.0) 2 (6.1) 1 (4.3) 3 (4.3)
Acinetobacter spp. 5 (38.5) 9 (27.3) 10 (43.5) 24 (34.8)
Pseudomonas spp. 4 (30.8) 3 (9.1) 1 (4.3) 8 (11.6)
CoNS 1 (7.7) 2 (6.1) 0 (0.0) 3 (4.3)
Total 13 (100) 33 (100) 23 (100) 69 (100)
Note: BSI: bloodstream infection; CR-BSI: catheter-related BSI; CoNS: coagulase-negative staphylococci.
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resistant to third-generation cephalosporins. Considering carbapenem resistance of
these bacteria, majority of isolates of Klebsiella spp. (85.7%), K. pneumoniae
(70%), and Providentia spp. (66.7%) were denoted as carbapenem resistant,
whereas no isolates of Proteus spp. and Seratia spp. were resistant to this class
of antimicrobial agents. Gram-negative rods, Pseudomonas spp. and Acinetobac-
ter spp., were highly resistant to carbapenems, as 87.5% and 95.8% of their
isolates, respectively, were not susceptible to this antibiotic. Of 24 isolates of
Acinetobacter spp., 4 (16.7%) were also resistant to colistin.
Discussion
In this study, we assessed the incidence of BSI in patients with trauma in
ICU of a major referral academic Emergency Center in Belgrade, Serbia, as well as
the fraction of BSI, which can be attributed to CVC exposure initiated in ED. In
addition, we sought to estimate which of the ED- and ICU-derived variables are
independent predictors of BSI and whether ED predictors significantly improve
that prediction. At least, we delineated distribution of causative agents of BSI and
the major AMR markers of these pathogens.
Table V. AMR markers in bacteria causing BSI in patients with trauma
Bacteria AMR marker n n (%) R
S. aureus MRSA 6 6 (100)
CoNS MRCoNS 3 3 (100)
Enterococcus spp. VRE 6 4 (66.7)
Klebsiella spp. 3GC-NS 17 17 (100)
CAR-NS 17 13 (76.5)
Proteus spp. 3GC-NS 1 1 (100)
CAR-NS 1 0 (0.0)
Serratia spp. 3GC-NS 1 1 (100)
CAR-NS 1 0 (0.0)
Providentia spp. 3GC-NS 3 3 (100)
CAR-NS 3 2 (66.7)
Pseudomonas spp. CAR-NS 8 7 (87.5)
CST-NS 8 0 (0.0)
Acinetobacter spp. CAR-NS 24 23 (95.8)
CST-NS 24 4 (16.7)
Note: AMR: antimicrobial resistance; BSI: bloodstream infection; MRSA: methicillin-resistant Staphylo-
coccus aureus; CoNS: coagulase-negative staphylococci; MRCoNS: Methicillin-resistant coagulase-
negative staphylococci; VRE: vancomycin-resistant enterococci; 3GC: third-generation cephalosporin;
CAR: carbapenem; CST: colistin; NS: non-susceptible.
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Cumulative incidence of BSI in this study was 14% and the incidence rate
was 11.8/1,000 patient/days. Similar to these findings, cumulative incidence in
studies that reported BSI as a primary outcome in patients with trauma was 15.2%
in American trauma ICU [20]. However, diverse results were reported within
wards and countries where BSI was analyzed as a fraction of all HAIs [21–26].
Regardless of heterogeneity of results, most of the studies focused on
incidence and risk factors for BSI acquired in ICU. The reason is that majority
of infections present upon admission to ED are community-acquired, whereas
those that occur later are usually, due to delayed diagnostic, identified upon
admission in ICU. Moreover, according to protocols and guidelines for surveil-
lance studies, if invasive device, such as vascular catheter, is inserted in ED and
signs and symptoms of infection occur in ICU, these are reported as ICU-acquired
BSI since ED is not considered as inpatient location and for which no denominator
data are collected [27]. The consequence is the attribution of ED-acquired HAI to
the ICU and underestimation of ED as a significant source of HAI. LeMaster et al.
[28] showed that in a study conducted in large urban academic hospital in Boston,
based on cases with vascular catheters inserted in ED, incidence of ED BSI is
similar to the rates of BSI in ICU. Moreover, Theodoro et al. [29] showed that
although ED contributes only 7.7% of total institutional catheter-days, incidence
of central line-associated BSI (CLABSI) in ED is similar to incidence in medical
and composite ICUs and it is higher compared to surgical ICU. No such study was
conducted in patients with trauma to date, especially not in low or middle income
countries. In this study, 15% of CR-BSIs were acquired in ED with the incidence
3.7/1,000 CVC-days, which is similar to BSI incidence in ICU (3.0/1,000
CVC-days). This can be partially explained by smaller number of CVC-days in
ED used as a denominator for incidence calculation. However, the results of this
study confirm findings from two previously mentioned studies conducted in
unselected population of critically ill patients in terms of considerable fraction
of BSI that can be attributed to ED and the similar incidence of BSI acquired in ED
and ICU. This is particularly important as it shows that exposure to CVC in ED is
significant in developing BSI and necessity of the adaptation of future preventative
strategies to include ED in CVC maintenance and hand hygiene guidelines.
We also sought to determine which variables regarding the patient’s and
trauma characteristic assessed in very first hours of ED admission are associated
with later occurrence of BSI together with variables from ICU. Factors identified
to independently predict occurrence of BSI in patients with trauma in this study
were lactate level ≥2 mmol/L and SOFA score at the admission to ED and CVC in
place for more than 7 days and mechanical ventilation for more than 7 days in ICU.
This is supported by results of previous studies, which also suggest that severity of
disease scores such as APACHE II and SOFA as well as days spent on mechanical
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ventilation and CVC in place is independently associated with HAI and BSI in
patients with trauma [22, 25, 26].
Lactate is widely accepted as marker of hypoperfusion, and its diagnostic
value in risk stratification for adverse outcomes has been frequently investigated in
diverse subpopulations of critically ill patients [30]. However, the studies mostly
focused on unselected ICU patients with suspected or confirmed infection or septic
shock and evaluated mortality as an outcome [31]. Several studies addressed this
issue within the ED patients and only few with respect to infection prediction. In a
study of prediction of bacteremia in adult patients admitted to Swedish ED,
Ljungström et al. [32] showed that lactate was significantly higher in patients with
bacteremia compared to those without infection (2.10 vs. 1.66 mmol/L) and that it
has as good predictive ability as a single biomarker as well as in composition with
other biomarkers. However, Lin et al. [33] showed that lactate level 19.9 mg/dl
(2 mmol/L) has slightly better diagnostic accuracy in prediction of Gram-positive
bacteremia than procalcitonin (AUC 0.66 vs. 0.61) in adult ED patients, but lower
accuracy in predicting Gram-negative bacteremia (AUC 0.71 vs. 0.79) and overall
positive blood culture (AUC 0.69 vs. 0.72). In this study, however, we do not have
in-depth information on other inflammation markers as lactate was selected as
marker of tissue damage following trauma and not as an infection diagnostic marker.
In this study, elevated lactate did not remain significant after adjustment for
patients’ characteristics, trauma severity, hemorrhagic shock, and severe TBI. This
result may suggest that increased lactate is only reflecting the severity of the
underlying condition motivating the use of CVC, which maintained the strongest
association with BSI in adjusted model. Although, in Serbia, CVCs are inserted
following CVC guidelines, and CVC management includes change of femoral
CVC after 2 days and subclavian and jugular CVC after 7 days of insertion [12],
high BSI incidence in ED and ICU can be attributed to possible low compliance to
these policies and lack of hygiene measures. Although such measures represent a
challenge in life-saving medical setting, they should not be neglected, considering
unfavorable outcomes of infections related to CVC use and the fact that great part
of CLABSI can be prevented just by adequate adherence to the components of the
CL bundles [34].
Considering AMR markers in causative pathogens of BSI, we found
alarmingly high rates of Enterobacteriaceae strains resistant to third-generation
cephalosporins (100% of strains) and carbapenems (66.7%–85.7%) as well as high
percentage of Pseudomonas spp. and Acinetobacter spp. resistant to carbapenems
(87.5% and 95.8% of non-susceptible strains, respectively). On the contrary,
National Healthcare Safety Network and International Nosocomial Infection
Control Consortium reported considerably lower rates of isolates resistant to
common AMR markers [35, 36]. Although there is no data available on resistance
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to common AMR markers of pathogens causing BSI in patients with trauma from
countries close to Serbia, our results are similar to AMR data of invasive isolates in
acute care hospitals in countries of Southeastern–European Region [37]. At
clinical level, this data is highly important since the choice of empirical therapy
of BSI/CLABSI and its duration depend on understanding the distribution and
resistance patterns of their causative agents in specific setting or patient popula-
tion. At national level, this imposes the necessity for implementation of measures
for antibiotic consumption restriction together with general and pathogen-specific
measures for disruption of transmission of resistant clones.
Several limitations of the study should be addressed. Collecting data from
one academic trauma center can be subject to selection bias due to inclusion of
mostly severe trauma cases. We did not have data on previous antibiotic
consumption due to the urgent type of referral. However, this is the first study
in Southeastern–European Region to outline epidemiology of BSI and to estimate
contribution of both ED and ICU incidence of BSI as well as contribution of ED
variables as risk factors of BSI in population of patients with trauma. Strength of
the study is prospective daily collection of numerous clinical and disease severity
variables, as well as assessment of signs of infections and the exposure to risk
factors with low possibility of misclassification of both exposure and outcome.
In conclusion, BSI is a common HAI in trauma ICU affecting 14% of all
inpatients in ICU. Considerable part of BSI in ICU arises in ED, resulting in
similar incidence of BSI in ED compared to ICU. In this study, combination of
predictors for BSI assessed in ED and those measured in ICU indicates that
constant monitoring of patients on MV and those with CVC for reassessing the
need for their continuation may be useful in order to detect primary BSI and
pneumonia-related secondary BSI, especially in patients who had hypoperfusion
and more severe condition on admission, as estimated by lactate level and SOFA
score. Predominance of primary BSI is caused by Gram-negative bacteria highly
resistant to commonly used antibiotics, stress necessity for more effective overall,
and CVC-specific infection control measures in critically ill patients with trauma.
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